Following encouraging results recently published in the Journal of Clinical Investigation describing the progress of a cohort of patients treated with Exenatide for their Parkinson’s disease (PD), The Michael J.…
Scientists based at the University of Edinburgh’s MRC Centre for Regenerative Medicine (CRM) and Anne Rowling Clinic have taken a vital step forward in understanding how cells from skin tissue…
Exenatide is a type 2 diabetes treatment that has been shown to have neuroprotective/neurorestorative properties in preclinical models of neurodegeneration. A new study by Aviles-Olmos et al published in the…
A new University of Florida study suggests a promising brain-imaging technique has the potential to improve diagnoses for the millions of people with movement disorders such as Parkinson’s disease. Science…
In a post dated 24 May, Science Daily reports that scientists at the German Centre for Neurodegenerative Diseases (DZNE) in Bonn have developed a novel experimental model that reproduces for…
A team of German researchers led by Jens Wagner, Sergey Ryazanov, Andrei Leonov, Johannes Levin and Song Shi, reports an important breakthrough in the search for disease-modifying therapy for Parkinson’s…